2019-NCOV/COVID-19 - Approaches to viral vaccine development and preventive measures

Muhammad Bilal, Muhammad Shahzad Nazir, Roberto Parra-Saldivar, Hafiz M.N. Iqbal

Research output: Contribution to journalArticle

1 Scopus citations


© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus (2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks. Among several epidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is an important measure to track record the overall proportion/ratio of the cumulative number of infected patients with the known outcome (confirmed, recovered, or deceased). Considering the ongoing fatality rate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viral vaccine development are discussed herein. The prompt identification of high-risk entities to confront the uncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement to tackle the current COVID-19 severity. Moreover, the protein visualization available at the viral surface/ body can give further insight into the appropriate vaccine development.
Original languageEnglish
JournalJournal of Pure and Applied Microbiology
Issue number1
StatePublished - 1 Mar 2020

Fingerprint Dive into the research topics of '2019-NCOV/COVID-19 - Approaches to viral vaccine development and preventive measures'. Together they form a unique fingerprint.

  • Cite this